Encelto (revakinagene taroretcel-lwey) is a cell-based implant designed to continuously deliver recombinant human ciliary neurotrophic factor (rhCNTF) within the retina. It is indicated for the treatment of adult patients with idiopathic macular telangiectasia type 2, non-proliferative, to slow photoreceptor degeneration and preserve visual function.
Localización de Nuestra Oficina principal:
Dirección Física:
1441 F.D. Roosevelt Ave.
San Juan, P.R. 00936
Dirección Postal:
P.O. Box 363628
San Juan, P.R. 00936-3628